Cargando…

Asymptomatic hyperuricemia is not an independent risk factor for cardiovascular events or overall mortality in the general population of the Busselton Health Study

BACKGROUND: To investigate the impact of uric acid (UA) levels on cardiovascular disease and mortality at a population level. METHODS: Prospective analysis of baseline serum UA measurement and 15 year follow-up data from the Busselton Health Survey (n = 4,173), stratified by existence or absence of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nossent, Johannes, Raymond, Warren, Divitini, Mark, Knuiman, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5160002/ https://www.ncbi.nlm.nih.gov/pubmed/27978810 http://dx.doi.org/10.1186/s12872-016-0421-1

Ejemplares similares

Rheumatoid factors do not predict cardiovascular disease and mortality in the general population in the Busselton Health Survey
por: Nossent, Johannes, et al.
Publicado: (2017)

A prospective cohort examination of haematological parameters in relation to cancer death and incidence: the Busselton Health Study
por: Adris, Niwansa, et al.
Publicado: (2018)

Prevalence and patterns of multimorbidity in Australian baby boomers: the Busselton healthy ageing study
por: Hunter, Michael L., et al.
Publicado: (2021)

Comparing self-reported and measured hypertension and hypercholesterolaemia at standard and more stringent diagnostic thresholds: the cross-sectional 2010–2015 Busselton Healthy Ageing study
por: Burvill, Angela J, et al.
Publicado: (2022)

Prevalence of Hyperacusis and Its Relation to Health: The Busselton Healthy Ageing Study
por: Smit, Adriana L., et al.
Publicado: (2021)

Rationale, design and methods for a community-based study of clustering and cumulative effects of chronic disease processes and their effects on ageing: the Busselton healthy ageing study
por: James, Alan, et al.
Publicado: (2013)

Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease
por: Waheed, Yousuf, et al.
Publicado: (2021)

Long-Term Associations between Human Cytomegalovirus Antibody Levels with All-Cause Mortality and Cardiovascular Outcomes in an Australian Community-Based Cohort
por: Lee, Silvia, et al.
Publicado: (2022)

Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment
por: Shin, Hong-Joon, et al.
Publicado: (2023)

Effect of Asymptomatic Hyperuricemia on Mortality of Elderly Patients After Elective Percutaneous Coronary Intervention
por: Chen, Chen, et al.
Publicado: (2022)

Comparison of Four Dietary Pattern Indices in Australian Baby Boomers: Findings from the Busselton Healthy Ageing Study
por: McDowell, Sierra R., et al.
Publicado: (2023)

Hyperuricemia and Cardiovascular Risk
por: Shahin, Lauren, et al.
Publicado: (2021)

To treat or not to treat asymptomatic hyperuricemia in chronic kidney disease
por: Shin, Dong Ho
Publicado: (2019)

Postsystolic Shortening by Speckle Tracking Echocardiography Is an Independent Predictor of Cardiovascular Events and Mortality in the General Population
por: Brainin, Philip, et al.
Publicado: (2018)

Relationship between oxidative stress and inflammation in hyperuricemia: Analysis based on asymptomatic young patients with primary hyperuricemia
por: Zhou, You, et al.
Publicado: (2018)

Alcohol Consumption and Cardiovascular Outcomes in Patients With Nonalcoholic Fatty Liver Disease: A Population‐Based Cohort Study
por: Janjua, Malik, et al.
Publicado: (2021)

U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia
por: Crawley, William T., et al.
Publicado: (2022)

Hyperuricemia Is Not an Independent Predictor of Erectile Dysfunction
por: Tuokko, Antti T., et al.
Publicado: (2021)

Risk of Major Adverse Cardiovascular Event Following Incident Hospitalization for Acute Gout: A Western Australian Population‐Level Linked Data Study
por: Lopez, Derrick, et al.
Publicado: (2023)

Hyperuricemia and Incident Cardiovascular Disease and Noncardiac Vascular Events in Patients with Rheumatoid Arthritis
por: Kuo, Daniel, et al.
Publicado: (2014)

Prognostic Value of Obesity on Both Overall Mortality and Cardiovascular Disease in the General Population
por: Ponce-Garcia, Isabel, et al.
Publicado: (2015)

Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome
por: Kim, Seoyoung C., et al.
Publicado: (2018)

Gut Microbiota Characterization in Patients with Asymptomatic Hyperuricemia: probiotics increased
por: Yang, Hai-Tao, et al.
Publicado: (2021)

Asymptomatic Hyperuricemia as an Independent Risk Factor for Myocardial Infarction in Adult Population: A Four-Year Follow-Up Study
por: Talpur, Abdul Subhan, et al.
Publicado: (2023)

Left-handedness and risk of breast cancer
por: Fritschi, L, et al.
Publicado: (2007)

Asymptomatic hyperuricemia and coronary artery disease in elderly patients without comorbidities
por: Wu, Junnan, et al.
Publicado: (2017)

Is Hyperuricemia, an Early-Onset Metabolic Disorder, Causally Associated with Cardiovascular Disease Events in Han Chinese?
por: Chiang, Kuang-Mao, et al.
Publicado: (2019)

Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus
por: Raymond, Warren, et al.
Publicado: (2018)

Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial
por: Eleftheriadis, Theodoros, et al.
Publicado: (2017)

Asymptomatic Hyperuricemia Associates with Cardiometabolic Risk Indicators in Overweight/Obese but Not in Lean Adolescents
por: Sebekova, Katarina, et al.
Publicado: (2020)

Comparison of Benzbromarone and Allopurinol on Primary Prevention of the First Gout Flare in Asymptomatic Hyperuricemia
por: Lai, Shih-Wei, et al.
Publicado: (2022)

Gegen Qinlian Decoction treatment of asymptomatic hyperuricemia by targeting circadian immune function
por: Wang, Xiaojun, et al.
Publicado: (2023)

Asymptomatic hyperuricemia associated with increased risk of nephrolithiasis: a cross-sectional study
por: Deng, Haoyuan, et al.
Publicado: (2023)

Risk of a major adverse cardiovascular event (MACE) following first-ever hospitalisation for acute gout: a Western Australian population-level linked data study.
por: Lopez, Derrick, et al.
Publicado: (2022)

Overall and cardiovascular mortality according to 10-year cardiovascular risk of the general health checkup: the Kangbuk Samsung Cohort Study
por: Jeong, Youshik, et al.
Publicado: (2022)

Mechanisms Linking Hyperuricemia to Increased Cardiovascular Risk
por: Kang, Eun Ha
Publicado: (2019)

Hyperuricemia as an Independent Predictor of Vascular Complications and Mortality in Type 2 Diabetes Patients: A Meta-Analysis
por: Xu, Yili, et al.
Publicado: (2013)

Vitamin D Levels Are Associated with Cardiovascular Disease Events but Not with Cardiovascular Disease or Overall Mortality: A Prospective Population-Based Study
por: Patriota, Pollyanna, et al.
Publicado: (2023)

Increased Overall Heart Rate Irregularity Risk by Hyperuricemia in the General Population: Results from the Korean National Health and Nutrition Examination Survey
por: Eun, Yeonghee, et al.
Publicado: (2020)

Asymptomatic hyperuricemia is independently associated with coronary artery calcification in the absence of overt coronary artery disease: A single-center cross-sectional study
por: Kim, Hyunwook, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2fr0ptfirgs5q2cb1c8o5et7lh